Collegium Pharmaceutical (COLL) PT Hiked to $34 at Needham & Company on Anticipated BioDelivery (BDSI) Synergies
Tweet Send to a Friend
Needham & Company analyst Serge Belanger raised the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $34.00 (from $28.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
